| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0008 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.18 | 0.001 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.15 | 0.001 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |